The biosecurity crossroads: Decline or dominance By Matthew McKnight Key Points The testimony argues that future global leadership will hinge on control of biology and bio-manufacturing, warning that failure to invest could leave the U.S... Read more Artificial intelligence and the future of biodefense readiness By Jassi Pannu Key Points While AI is advancing rapidly in commercial biology and medicine, biosecurity and biodefense applications remain under-incentivized by the private sector, requiri... Read more Why a private investor is putting billions into women’s health care By HPN Staff Key Points The Gates Foundation committed $2.5 billion over five years to accelerate research and innovation in women’s health, its largest-ever investme... Read more Screwworm threat found in U.S. By HPN Staff Key Points The first U.S. human case of New World screwworm was confirmed in Maryland, but officials say public health risk remains very low. ... Read more FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Maryland
Artificial intelligence and the future of biodefense readiness By Jassi Pannu Key Points While AI is advancing rapidly in commercial biology and medicine, biosecurity and biodefense applications remain under-incentivized by the private sector, requiri... Read more Why a private investor is putting billions into women’s health care By HPN Staff Key Points The Gates Foundation committed $2.5 billion over five years to accelerate research and innovation in women’s health, its largest-ever investme... Read more Screwworm threat found in U.S. By HPN Staff Key Points The first U.S. human case of New World screwworm was confirmed in Maryland, but officials say public health risk remains very low. ... Read more FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Maryland
Why a private investor is putting billions into women’s health care By HPN Staff Key Points The Gates Foundation committed $2.5 billion over five years to accelerate research and innovation in women’s health, its largest-ever investme... Read more Screwworm threat found in U.S. By HPN Staff Key Points The first U.S. human case of New World screwworm was confirmed in Maryland, but officials say public health risk remains very low. ... Read more FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Maryland
Screwworm threat found in U.S. By HPN Staff Key Points The first U.S. human case of New World screwworm was confirmed in Maryland, but officials say public health risk remains very low. ... Read more FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Maryland
FDA’s top vaccine official returns to post after controversial resignation By HPN Staff Key Points Dr. Vinay Prasad resigned as head of the FDA’s Center for Biologics Evaluation and Research (CBER) after controversy over halting Sarepta’s g... Read more Subscribe to Maryland
